Evidence map›Paper›PMID 31263982›Full record

ArticleEuropean journal of nutrition2020

Commercial complementary food use amongst European infants and children: results from the EU Childhood Obesity Project.

Melissa A Theurich, Marta Zaragoza-Jordana, Veronica Luque, Dariusz Gruszfeld, Kinga Gradowska, Annick Xhonneux, Enrica Riva, Elvira Verduci, Pascale Poncelet, Louiza Damianidi and 2 more

Open access · hybridAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Melissa A TheurichDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Lindwurmstr. 4, 80337, Munich, Germany.ORCID http://orcid.org/0000-0001-8928-9004
Marta Zaragoza-JordanaUniversitat Rovira i Virgili, IISPV, Tarragona, Spain.ORCID http://orcid.org/0000-0001-9704-6950
Veronica LuqueUniversitat Rovira i Virgili, IISPV, Tarragona, Spain.ORCID http://orcid.org/0000-0003-2615-8175
Dariusz GruszfeldNeonatal Department, Children's Memorial Health Institute, Warsaw, Poland.ORCID http://orcid.org/0000-0002-2414-4928
Kinga GradowskaNeonatal Department, Children's Memorial Health Institute, Warsaw, Poland.ORCID http://orcid.org/0000-0002-0913-8116
Annick XhonneuxCHC St Vincent, Liège-Rocourt, Belgium.
Enrica RivaUniversity of Milan, Milan, Italy.ORCID http://orcid.org/0000-0002-6623-1800
Elvira VerduciUniversity of Milan, Milan, Italy.ORCID http://orcid.org/0000-0003-2111-3111
Pascale PonceletQueen Fabiola Children's University Hospital, Université Libre de Bruxelles, Brussels, Belgium.ORCID http://orcid.org/0000-0001-8478-9691
Louiza DamianidiDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Lindwurmstr. 4, 80337, Munich, Germany.ORCID http://orcid.org/0000-0001-6674-3745
Berthold KoletzkoDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Lindwurmstr. 4, 80337, Munich, Germany. office.koletzko@med.lmu.de.ORCID http://orcid.org/0000-0002-5345-7165
Veit GroteDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Lindwurmstr. 4, 80337, Munich, Germany.ORCID http://orcid.org/0000-0001-7168-2385
Ludwig-Maximilians-Universität München · DEUniversité Libre de Bruxelles · BEChildren's Memorial Health Institute · PLUniversity of Milan · ITCentre Hospitalier Chrétien · BELMU Klinikum · DE

Funding

European Commission DYNAHEALTH (H2020-633595)European Commission Early Nutrition (FP7-289346)European Commission LIFECYCLE (H2020-SC1-2016-RTD)European Research Council META-GROWTH (ERC-2012-AdG 322605)
6 · The paper itself

Abstract

purposeThe objective of this secondary analysis is to describe the types of commercial complementary foods (CCF) consumed by infants and young children enrolled in the European Childhood Obesity Project (CHOP), to describe the contribution of CCF to dietary energy intakes and to determine factors associated with CCF use over the first 2 years of life.

methodsThe CHOP trial is a multicenter intervention trial in Germany, Belgium, Italy, Poland and Spain that tested the effect of varying levels of protein in infant formula on the risk for childhood obesity. Infants were recruited from October 2002 to June 2004. Dietary data on CCF use for this secondary analysis were taken from weighted, 3-day dietary records from 1088 infants at 9 time points over the first 2 years of life.

resultsReported energy intakes from CCF during infancy (4-9 months) was significantly higher (p ≤ 0.002) amongst formula-fed children compared to breastfed children. Sweetened CCF intakes were significantly higher (p ≤ 0.009) amongst formula-fed infants. Female infants were fed significantly less CCF and infant age was strongly associated with daily CCF intakes, peaking at 9 months of age. Infants from families with middle- and high-level of education were fed significantly less quantities of CCF compared to infants with parents with lower education. Sweetened CCF were very common in Spain, Italy and Poland, with over 95% of infants and children fed CCF at 9 and 12 months of age consuming at least one sweetened CCF. At 24 months of age, 68% of the CHOP cohort were still fed CCF.

conclusionsCCF comprised a substantial part of the diets of this cohort of European infants and young children. The proportion of infants being fed sweetened CCF is concerning. More studies on the quality of commercial complementary foods in Europe are warranted, including market surveys on the saturation of the Western European market with sweetened CCF products.

Indexed as

Breast FeedingCohort StudiesDietEnergy IntakeEuropeFemaleHumansInfantInfant FoodInfant FormulaInfant Nutritional Physiological PhenomenaMalePediatric ObesitySocioeconomic FactorsBaby foodsCommercial complementary foodsComplementary feedingEuropeSugar

Identifiers

PMID31263982
OpenAlexW2954854861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.